Low-dose Recombinant Human IL-2 for the Treatment of Relapsing Polychondritis

Relapsing Polychondritis

Longitudinal Study for Relapsing Polychondritis Tocilizumab for Relapsing Polychondritis Study on the Safety of Abatacept in Relapsing Polychondritis Low-dose Recombinant Human IL-2 for the Treatment of Relapsing Polychondritis Single Patient Study to Treat Relapsing Polychondritis With Tocilizumab